SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sappi Limited (SPPJY) , forward earnings yield 3.76%. PEG 0.17 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 26.6
- PEG Ratio 0.17 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SPPJY
Valuation Multiples
P/E (TTM)0.0
Forward P/E26.6
PEG Ratio0.17
Forward PEG0.17
P/B Ratio0.00
P/S Ratio0.12
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.29
Forward EPS (Est.)$0.04
Book Value / Share$0.00
Revenue / Share$8.95
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield3.76%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.59 |
$5.14B |
$319M |
6.2% |
| 2017 |
$0.62 |
$5.3B |
$338M |
6.4% |
| 2018 |
$0.59 |
$5.81B |
$323M |
5.6% |
| 2019 |
$0.39 |
$5.75B |
$211M |
3.7% |
| 2020 |
$-0.25 |
$4.61B |
$-135M |
-2.9% |
| 2021 |
$0.02 |
$5.27B |
$13M |
0.2% |
| 2022 |
$0.89 |
$7.3B |
$536M |
7.3% |
| 2023 |
$0.43 |
$5.81B |
$259M |
4.5% |
| 2024 |
$0.06 |
$5.46B |
$33M |
0.6% |
| 2025 |
$-0.29 |
$5.4B |
$-176.48M |
-3.3% |
